Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma

Journal of the National Cancer Institute

Volumn 87, Issue 23, 1995, Pages 1798-1799

  Fox, Stephen B ^a   Gatter, Kevin C ^a   Altman, Douglas G ^b   Leek, Russel D ^c   Harris, Adrian L ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; BREAST TUMOR; FEMALE; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NOTE; PROGNOSIS; VASCULARIZATION;

BREAST NEOPLASMS; CARCINOMA, INFILTRATING DUCT; FEMALE; HUMAN; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0029638233     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.23.1798     Document Type: Letter

References (17)

1. Axelsson K, Ljung BM, Moore DH 2nd, Thor AD, Chew KL, Edgerton SM, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma, J Natl Cancer Inst 1995;87:997-1008.
2. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred E, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma, J Natl Cancer Inst 1992:84:187-587.
3. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
4. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma, bit J Cancer 1993:55:37.
5. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
6. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart M, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
7. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL. Tumor angiogenesis in node-negative breast carcinomas relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 1994;29:109-16.
8. Fox SB, Turner G, Leek R, Whitehouse R, Gatter KC, Harris AL. The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumour endothelium. Breast Cancer Res Treat 1995;36:219-26.
9. Chalkley H. Method for the quantitative morphological analysis of tissues. J Natl Cancer Inst 1943;4:47-53.
10. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J Pathol. In press.
11. Giatromanolaki A, Koukourakis M, O’Byme K, Fox SB, Whitehouse R, Talbot DC, et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol. In press.
12. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994;74:762-6.
13. Simon R, Altman D. Statistical aspects of prognostic factor studies in oncology, Br J Cancer 1994;69:979-85.
14. Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results [published erratum appears in Ann Intern Med 1995; 122:478
15. Olivarez D, Ulbright T, DeRiese W, Foster R, Reister T, Einhom L., et al. Neovascularization in clinical stage A testicular germ cell tumor prediction of metastatic disease. Cancer Res 1994;54:2800-2.
16. Protopapa E, Delides GS, Revesz L. Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. Eur J Cancer 1993;29A, 1391-3.
17. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using optimal cutpoints in the evaluation of prognostic factors [see comment citation in Medline]. J Natl Cancer Inst 1994;86:829-35.